We have investigated the effect of a series of steroidal oestrogen antagonists, related to ICI 164,384, on the DNA binding activity of mouse oestrogen receptors expressed in insect cells. The analogues possess different side chains at the 7-position of the B ring In the steroid. Inhibition was observed when the length of the side-chain was 15-16 carbon atoms but not 10 or 20 carbon atoms and only when the 7a isomer was used. The DNA binding activity of receptors expressed in COS-1 cells was also inhibited after extended periods of incubation with antioestrogens but not that of the human receptor in breast cancer cell-extracts. We have proposed that ICI 164,384 might disrupt receptor dimerisatlon, and therefore the variation in its ability to inhibit DNA binding activity may reflect differences in dimer stability. Since the DNA binding activity of in vitro translated receptors was inhibited when they were translated in the presence of the antioestrogen we suggest that ICI 164,384 might prevent the formation of receptor dimers without necessarily being able to disrupt preformed dimers.
INTRODUCTION
The mitogenic effects of oestrogens on cell growth are mediated by specific nuclear receptors that function as transcription factors [1] [2] [3] . Hormone binding is required to promote receptor dimerisation, high affinity DNA binding [4, 5] and to produce the full transcriptional activity of the receptor [6] [7] [8] [9] . Since oestrogens have been found to stimulate the growth of at least 30% of breast cancers a large number of oestrogen antagonists have been developed as potential therapeutic drugs. One type, which includes the non-steroidal drug tamoxifen [10] , appears to promote DNA binding but fails to induce the full transcriptional activity of the receptor [11] . In view of the partial agonist activity of tamoxifen in a number of physiological responses additional antioestrogens have been developed which are reported to be devoid of agonist activity [12, 13] .
The mechanism of action of so-called pure antioestrogens, such as ICI 164,384, is controversial. In our studies with the mouse oestrogen receptor we demonstrated that ICI 164,384 was able to inhibit DNA binding of the receptor in vitro [14] and to reduce its half-life and cellular content in cultured cells [15] . A rapid loss of oestrogen receptor has also been observed in uterine tissue after mice were injected with ICI 164,384 [16] . Other workers, however, have proposed that it interferes with a subsequent step required for receptor mediated gene transcription [17, 18] .
The variation in the ability of ICI 164,384 to inhibit DNA binding activity of the oestrogen receptor might be explained by differences in the stability of receptor dimers. In this paper we have investigated two aspects of DNA binding in vitro. First we tested the effect of a series of analogues related to ICI 164,384 and observed that their ability to inhibit DNA binding depended on the length of their 7a side chain. Secondly we demonstrate that inhibition is dependent on the time of incubation of receptors with antagonist and is obtained only when the antioestrogen is bound to receptor prior to its binding to DNA.
MATERIALS AND METHODS Materials
The following analogues of ICI 164,384 [13, 19] were kindly given to us by Dr. MP16 is an anti-peptide rabbit antiserum raised against residues 130-142 in the mouse oestrogen receptor [14] . H222 is a rat monoclonal antibody raised against the human oestrogen receptor [20] kindly provided by C. Nolan (Abbot Laboratories, Chicago, USA). Peroxidase-conjugated rabbit and goat immunoglobulins were obtained from Dakopatts (Glostrup, Denmark). Prestained SDS-PAGE Standards were obtained from Bio-Rad (Hemel Hempstead, UK).
Expression of mouse oestrogen receptors
Mouse oestrogen receptor (MOR) was expressed in Spodoptera frugiperda cells using a recombinant baculovirus vector and in transiently transfected COS-1 cells using a SV40-based expression vector. The S. frugiperda cells were grown as monolayers in Grace's medium (Gibco, Paisley, Scotland) supplemented with 10% (v/v) fetal calf serum (Gibco) and infected with virus at a multiplicity of infection of 5 -10 plaque forming units per cell as previously described [14] . COS-1 cells were grown as monolayers in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal calf serum, 8 xlO 6 cells were transfected with 25/*g of pJ3MOR [21] by electroporation at 450V and 250/iF using a Biorad Gene pulser as previously described [15] .
Whole cell extracts were prepared in high salt buffer containing 0.4 M KC1, 20 mM Hepes pH 7.4, 1 mM dithiothreitol (DTT), 20% (v/v) glycerol, 0.5mg/ml bacitracin, 5/tg/ml aprotinin, 40/tg/ml phenyl methylsulfonyl fluoride (PMSF), 5/ig/ml pepstatin and 5ftg/ml leupeptin [ 14] . The protein concentration of all whole cell extracts was determined with a Biorad protein assay reagent and used to normalise the amount of extract examined in gel shift assays.
Gel shift assays
The DNA binding activity of oestrogen receptors was assayed by gel shift analysis [22] . Whole cell extracts from infected 5. frugiperda cells (0.2/tg protein) or transfected COS-1 cells (2/xg protein) were preincubated with the indicated ligands in 20 /tl of binding buffer (20 mM HEPES pH 7.4, 50 mM KC1, 1 mM DTT and 10% (v/v) glycerol) with ljig of poly(dI-dC)-(dI-dC) and 100/ig of bovine serum albumin (BSA) at room temperature for 10 min to 4 hours as indicated. In some experiments antiserum MP16 or preimmune serum was also added at the end of the binding reaction. Radiolabelled double-stranded oligodeoxynucleotide probe (1 ng) containing an oestrogen response element [22] was then added and the samples were incubated for a further 30 min unless otherwise indicated. Samples were analysed by electrophoresis and autoradiography as previously described [22] .
In vitro synthesis of oestrogen receptors
Recombinant receptor cDNA clones were linearised with restriction enzyme, transcribed with SP6 polymerase and the RNA used to program protein synthesis in a rabbit reticulocyte lysate [22] . In some cases the receptor was translated in the presence of ligands at concentrations as indicated. Parallel translations were carried out in the presence of a portion of [ 
Western blot analysis
Protein samples (10 ng) were separated on a 10% (w/v) SDS polyacrylamide gel and transferred to nitrocellulose in a buffer containing 25mM Tris pH 8.3, 190 mM glycine and 20% (v/v) methanol. After blocking with 3% (w/v) gelatin receptors were detected with antibodies H222 and MP16 (each at 10/tg/ml) using peroxidase-conjugated rabbit immunoglobulins (for H222) or goat immunoglobulins (for MP16) and horseradish colour development (Bio-rad laboratories) according to the suppliers instructions.
RESULTS
The DNA binding activity of oestrogen receptors expressed from a baculoviral vector in insect cells was investigated in the presence of a series of steroidal oestrogen antagonists containing different side chains at the 7a-position. Since the Kd of the receptor for oestradiol was 0.3nM [Fawell. S.E. unpublished] and the relative binding affinities of the analogues were equal to or greater than 0.01 that of oestradiol (Table 1) During the course of optimising the conditions for analysing the DNA binding activity of the oestrogen receptor it was noted that the effect of ICI 164,384 depended upon a number of parameters. First, DNA binding was inhibited only when the antioestrogen was added to receptor prior to the addition of DNA. When receptor was pre-bound to DNA antioestrogen treatment for periods of time up to 4 hours failed to reduce DNA binding (Figure 2) . Secondly, when receptors were incubated in the absence of DNA for extended periods of time their DNA binding activity and the ability of MP16 to rescue binding in the presence of ICI 164,384 was observed to decrease (Figure 3) . To investigate whether this could be accounted for by receptor degradation, the amount of receptor was assessed by Western blotting (Figure 4) . No degradation of receptor was detected using antibodies MP16 or H222, whose epitopes are located between residues 130-142 [14] and 463-528 [6] respectively, suggesting that DNA binding activity itself was somehow impaired.
Nucleic Acids Research, Vol. 20, No. 15 3841 We next determined the effect of antioestrogens on the DNA binding activity of oestrogen receptors in mammalian cells by transiently expressing the receptor in COS-1 cells. Initially we observed little effect of ICI 164,384 when we used conditions suitable for inhibiting the DNA binding of receptors expressed in insect cells. However, the DNA binding activity of receptors expressed in COS-1 cells was reduced when the time of incubation of receptor with antioestrogen was extended from 10 mins to one hour (Figure 5a) . Inhibition of DNA binding activity was also observed when we incubated receptor with the more potent antioestrogens ICI 165,801 and ICI 182,780 for 10 minutes and could be restored by the addition of the MP16 antibody (Figure 5b) .
In contrast to the results that we have obtained with receptors transiently expressed in insect or mammalian cells we have failed to demonstrate a significant effect of ICI 164,384 on the DNA binding activity of human oestrogen receptors in extracts of ZR 75-1 breast cancer cells ( Figure 6 ). Moreover the more potent antioestrogens ICI 165,801 and ICI 182,780 foiled to inhibit DNA binding ( Figure 6 ). However, inhibition was observed when receptors were incubated with antioestrogen for extended periods of time but DNA binding was not rescued with antibody MP16 (data not shown).
Previous work also failed to demonstrate an effect of ICI 164,384 on in vitro translated receptors [9] . As an alternative approach we analysed the effect of synthesising the receptor in vitro in the presence of antioestrogens. The receptor was translated in the presence of either oestradiol, ICI 164,384 or ICI 182,780, at concentrations which did not affect translational efficiency. The presence of either antioestrogen, in contrast to oestradiol, resulted in inhibition of DNA binding activity which could be partially rescued by antibody MP16. (Figure 7 ). Control experiments with [ 35 S] methionine labelled receptor confirmed that loss of DNA binding activity was not due to receptor degradation (data not shown).
DISCUSSION
The steroidal oestrogen antagonist ICI 164,384 has been shown to be devoid of oestrogenic activity in vivo [12, 13, 24] , in breast cancer cells [24] [25] [26] and in transiently transfected cells [11, 14] . The ability of ICI 164,384 analogues to act as pure antioestrogens in the rat uterus has been shown to depend on the length of the amidoalkyl side chain at the 7a-position [13] . We have compared the effects of a series of antioestrogens related to ICI 164,384 on the DNA binding activity of oestrogen receptors in vitro. The derivatives which act as complete antagonists in vivo, namely ICI 163,964, ICI 164,384, ICI 165,801 and ICI 182,780, all inhibited DNA binding activity in vitro whereas those that showed partial agonist properties were without effect. While the ability of the antioestrogen to inhibit DNA binding broadly parallels their affinity for receptor the results obtained with ICI 165,889 indicate that affinity alone is unlikely to account for differences in the effect of the antioestrogens. This antioestrogen has an affinity for receptor of about one-fifth that of ICI 164,384 and ICI 182780 but fails to inhibit DNA binding even at concentrations 10-fold higher than is necessary for ICI 164,384 and ICI 182780 to inhibit DNA binding.Thus there is a good correlation between the ability of the ICI 164,384 analogues to act as pure antioestrogens in vivo and their ability to inhibit DNA binding in vitro.
Recently it has been found that ICI 164,384 reduces the cellular content of oestrogen receptors in the mouse uterus and in mouse testes TM4 cells [16] . We have demonstrated that the antioestrogen also reduces oestrogen receptor content in transfected COS-1 cells and in human breast cancer cells [15] . This reduction could not be accounted for by alterations in receptor mRNA but resulted from an increase in the turnover of receptor protein since pulse-chase labelling experiments with COS-1 cells indicate that its half-life was reduced from approximately 5 hours to less than 1 hour by ICI 164,384 binding [15] . We have previously shown that a number of residues essential for oestrogen binding are also involved in receptor dimerisation [22] . Since the steroidal antioestrogens are likely to bind to a similar region of the receptor as oestradiol we have postulated that the 7a-alkylamide side chain might sterically interfere with protein dimerisation [14] . Impaired receptor dimerisation might explain the inhibition of DNA binding activity by ICI 164,384 that has been observed in vitro in view of the 20-fold reduction in the affinity with which the monomeric DNA binding domain binds to DNA compared with the intact dimeric receptor [22, 28] . We have suggested previously that impaired receptor dimerisation upon ICI 164,384 binding might also account for the increase in the turnover of oestrogen receptors observed in vivo [15] .
In addition to the effect of ICI 164,384 on receptor turnover we can not rule out the suggestion that it may also antagonise oestrogen receptor activity by inhibiting its transcriptional activity directly. Support for this proposal comes mainly from the use of chimeric receptor proteins which seem to be able to bind to DNA in intact cells even in the presence of ICI 164,384 [7, 18] . However, these chimeric proteins might be processed differently from the normal receptor since they may contain additional dimerisation domains [7, 18, 29] which could function even when ICI 164,384 is bound to the hormone binding domain.
While ICI 164,384 was able to inhibit the DNA binding activity of mouse oestrogen receptors expressed in insect cells and COS-1 cells ( Figure 5 and [30] ) and of partially purified receptors from human or pig uterus [31] the DNA binding activity of oestrogen receptors from a number of other sources was unaffected ( Figure 6, [17,32] ). These conflicting observations have prompted us to suggest that variations in the effect of the antioestrogen may reflect differences in the stability of receptor dimers in cells [15] . This suggestion is supported by two observations. Firstly, inhibition of DNA binding activity depends on the time of incubation with antioestrogen, being particularly evident with receptors expressed in COS-1 cells. Secondly, the antioestrogen had no effect when receptors were prebound to DNA, a condition when they are likely to be stabilised as dimers. It is doubtful whether differences in the overall structure of their hormone binding domain can account for variations in the sensitivity of receptors to ICI 164,384 since they all have a similar affinity for oestradiol [9 and Fawell.S.E. unpublished]. Alternatively, given the recent identification of a cofactor that regulates dimerisation of the hepatocyte nuclear factor la transcription factor [33] , functionally analogous proteins may also be involved in stabilising steroid receptor dimers.
Our observation that ICI 164,384 or ICI 182,780 could inhibit the DNA binding activity of in vitro translated oestrogen receptors when the antioestrogens were present during the translation is consistent with the hypothesis that they are able to prevent the formation of receptor dimers without necessarily being able to disrupt them once they have been formed. Similarly ICI 164,384 might inhibit the dimerisation of receptors in human breast cancer cells but not when added to preformed dimers in cell-free extracts. This may then explain previous observations that the antioestrogen is capable of increasing the turnover of receptors in intact cells without being able to inhibit their DNA binding activity in vitro.
